Publications by authors named "Neal Slatkin"

Claim this Profile
I
Impact of Patient Subgroups on the Efficacy and Safety of Methylnaltrexone for Opioid-Induced Constipation in Patients with Advanced Illness.
Neel Mehta, Neal E Slatkin, Robert J Israel, Nancy Stambler, Eric D Shah

J Pain Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylnaltrexone Treatment for Opioid-Induced Constipation in Patients with and without Cancer: Effect of Initial Dose.
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler, Robert J Israel

J Pain Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reductions in All-Cause Mortality Associated with the Use of Methylnaltrexone for Opioid-Induced Bowel Disorders: A Pooled Analysis.
Lynn R Webster, Darren Brenner, Robert J Israel, Nancy Stambler, Neal E Slatkin

Pain Med· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Double-Blind, Parallel Design Thorough QT Study With a Nested Crossover to Compare the Cardiac Safety of Amiselimod With Placebo and Positive Control in Healthy Volunteers.
Jimin Lee, Robert Lester, Terry O'Reilly, Ezra R Lowe, Neal E Slatkin

Clin Pharmacol Drug Dev· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative Laxation Response with Methylnaltrexone: Implications for Hospitalized Patients with Advanced Illness and Opioid-Induced Constipation.
David Farchadi, Neal E Slatkin, Nancy Stambler, Robert J Israel, Michael Matus

Curr Ther Res Clin Exp· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid-Induced Constipation: Cost Impact of Approved Medications in the Emergency Department.
W Frank Peacock, Neal Slatkin, Patrick Gagnon-Sanschagrin, Jessica Maitland, Annie Guérin

Adv Ther· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Dose Efficacy of Methylnaltrexone in Patients with Severe Medical Illness and Opioid-Induced Constipation: A Pooled Analysis.
W Frank Peacock, Neal E Slatkin, Robert J Israel, Nancy Stambler

J Emerg Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P029 Pharmacokinetic/Pharmacodynamic Analysis of Amiselimod, a Selective Sphingosine 1-Phosphate Receptor Modulator, in Healthy Subjects: Results From a Phase 1 Study.
Jimin Lee, Robert Lester, Terry O'Reilly, Ezra Lowe, Neal Slatkin

Am J Gastroenterol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of brain metastases on the central nervous system effects of methylnaltrexone: a post hoc analysis of 3 randomized, double-blind studies.
Darren M Brenner, Neal E Slatkin, Nancy Stambler, Robert J Israel, Paul H Coluzzi

Support Care Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous Methylnaltrexone for Treatment of Opioid-Induced Constipation in Cancer versus Noncancer Patients: An Analysis of Efficacy and Safety Variables from Two Studies.
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler, Robert J Israel

J Pain Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attrition of methylnaltrexone treatment-emergent adverse events in patients with chronic noncancer pain and opioid-induced constipation: a post hoc pooled analysis of two clinical trials.
Neel Mehta, Neal E Slatkin, Robert J Israel, Nancy Stambler

F1000Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
Solomon S Liao, Neal E Slatkin, Nancy Stambler

Drugs Aging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The Influence of Age on Central Effects of Methylnaltrexone in Patients with Opioid-Induced Constipation.
Solomon S Liao, Neal E Slatkin, Nancy Stambler

Drugs Aging· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P014 Analysis of QT Interval Prolongation of Amiselimod in Healthy Subjects: A Phase 1 Randomized Controlled Trial.
Hanauer Stephen, O'Reilly Terry, Lester Robert, Slatkin Neal, Lee Jimin

Am J Gastroenterol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous methylnaltrexone for opioid-induced constipation in advanced-illness patients with or without active cancer.
Bruce H Chamberlain, Michelle Rhiner, Neal E Slatkin, Nancy Stambler, Robert J Israel

Pain Manag· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fulranumab as Adjunctive Therapy for Cancer-Related Pain: A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study.
Neal Slatkin, Naim Zaki, Steven Wang, John Louie, Panna Sanga

J Pain· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of oral methylnaltrexone for opioid-induced constipation in patients with chronic noncancer pain.
Richard L Rauck, Neal E Slatkin, Nancy Stambler, Robert J Israel

J Pain Res· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
Richard Rauck, Neal E Slatkin, Nancy Stambler, Joseph R Harper, Robert J Israel

Pain Pract· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
Srinivas R Nalamachu, Joseph Pergolizzi, Robert Taylor, Neal E Slatkin, Andrew C Barrett

Pain Pract· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of abdominal pain during methylnaltrexone treatment of opioid-induced constipation in advanced illness: a post hoc analysis of two clinical trials.
Neal E Slatkin, Richard Lynn, Chinyu Su, Wenjin Wang, Robert J Israel

J Pain Symptom Manage· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent and clinically relevant effects with fentanyl buccal tablet in the treatment of patients receiving maintenance opioid therapy and experiencing cancer-related breakthrough pain.
Giovambattista Zeppetella, John Messina, Fang Xie, Neal E Slatkin

Pain Pract· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term tolerability and effectiveness of oxymorphone extended release in patients with cancer.
Neal E Slatkin, Michelle I Rhiner, Errol M Gould, Tina Ma, Harry Ahdieh

J Opioid Manag· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Opioid switching and rotation in primary care: implementation and clinical utility.
Neal E Slatkin

Curr Med Res Opin· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
Neal Slatkin, Jay Thomas, Arthur G Lipman, George Wilson, Michelle L Boatwright

J Support Oncol· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative care and pain: new strategies for managing opioid bowel dysfunction.
Jay R Thomas, Gail Austin Cooney, Neal E Slatkin

J Palliat Med· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis